Newsmeme!
Discover News you didn't know existed
Granulocyte
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
02.12.2008 - DJ HUGIN NEWS/Micromet Expands Committed Equity Financing Facility to $75 Million
Published December 2, 2008, 5:23 am, 4investors
Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. =--------------------------------------------------------------------- =-------------
Micromet Expands Committed Equity Financing Facility to $75 Million
Published December 2, 2008, 4:00 am, PR Newswire via Yahoo! Finance
Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has entered into an agreement expanding its Committed Equity Financing Facility with Kingsbridge Capital Limited, a private investment group.
Antibodies against GM-CSF get US patent to treat inflammatory disorders
Published November 28, 2008, 4:50 am, PharmaBiz
MorphoSys AG and the University of Melbourne announced that the US Patent & Trademark Office (USPTO) has confirmed that it will issue US Patent No 7,455,836, covering key uses of antibodies against GM-CSF.
Micromet Added to NASDAQ Biotechnology Index
Published November 26, 2008, 11:28 am, PR Newswire via Yahoo! Finance
Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it was added to the NASDAQ Biotechnology Index® , effective November 24, 2008.
Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
Published November 26, 2008, 11:00 am, PR Newswire via Yahoo! Finance
Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its President and Chief Executive Officer, Dr.
(AFX UK Focus) 2008-11-26 17:48 U.S. FDA advisory meetings through Jan 8
Published November 26, 2008, 10:20 am, Interactive Investor
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EST/GMT.
MorphoSys to receive US patent for key antibody
Published November 26, 2008, 3:39 am, Pharmaceutical Business Review
MorphoSys, a biotechnology company, and the University of Melbourne have announced that the US Patent & Trademark Office has confirmed that it will issue a US patent covering key uses of antibodies against GM-CSF.
Stem Cell Therapeutics Corp. Announces Third Quarter 2008 Financial Results and Provides Corporate Update
Published November 25, 2008, 3:25 pm, CCNMatthews via Yahoo! Finance
CALGARY, ALBERTA-- - Stem Cell Therapeutics Corp. today announced its financial results for the period ended September 30, 2008.
Key US Patent Granted On Antibodies Against GM-CSF To Treat Inflammatory Disorders (Rheumatoid Arthritis)
Published November 25, 2008, 8:12 am, Medical News Today
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and the University of Melbourne announced today that the U.S. Patent & Trademark Office (USPTO) has confirmed that it will issue U.S. Patent No. 7,455,836, covering key uses of antibodies against GM-CSF. The patent stems from a provisional patent application filed in the USPTO in 2000 by the University of Melbourne.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |